Previous Close | 681.20 |
Open | 680.40 |
Bid | 705.50 x N/A |
Ask | 705.60 x N/A |
Day's Range | 670.00 - 706.40 |
52 Week Range | 470.10 - 736.30 |
Volume | |
Avg. Volume | 758,693 |
Market Cap | 168.948B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 58.16 |
EPS (TTM) | 12.14 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 645.00 |
The Indian market has shown robust performance, rising 1.2% over the last week and climbing 41% in the past year, with earnings forecasted to grow by 17% annually. In this thriving environment, identifying stocks with strong fundamentals and growth potential can be particularly rewarding.
PRINCETON, N.J. and BENGALURU, India, July 11, 2024 (GLOBE NEWSWIRE) -- Indegene today announced a strategic collaboration with Microsoft to empower global life sciences companies to scale up the adoption of purpose-built, enterprise-grade Generative AI (GenAI) services, thereby driving faster innovation at scale. Indegene and Microsoft have committed to developing resources in highly specialized and skilled medical and technology tools to co-innovate generative AI services and workflows across